Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Physicians & Subscribers
    • Benefits for Canadian physicians
    • CPD Credits for CMA Members
    • Subscribe to CMAJ Print
    • Subscription prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Physicians & Subscribers
    • Benefits for Canadian physicians
    • CPD Credits for CMA Members
    • Subscribe to CMAJ Print
    • Subscription prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Instagram
  • Listen to CMAJ podcasts
News

Urgent need for federal investment in research on cannabis health impacts, say researchers

Paul Webster
CMAJ February 05, 2018 190 (5) E149-E150; DOI: https://doi.org/10.1503/cmaj.109-5554
Paul Webster
Toronto, Ont.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Responses
  • Metrics
  • PDF
Loading

With the deadline for legalization of nonmedical marijuana approaching, scientists studying the health impacts of cannabis are calling on the federal government to implement a comprehensive research program.

“Considerably more funding has to be made available,” said Dr. Mark Ware, a pain researcher at McGill University.

At McMaster University, Dr. Suzanne Archie, who researches links between youth cannabis use and schizophrenia, said she has yet to see any appreciable upswing in federal research support. “There’s been no new funding recently in our area,” she said. “I’ve seen no calls for research.”

This concern was echoed by Dr. Jürgen Rehm, a senior scientist at the Centre for Addiction and Mental Health. “I see little sign that the federal government is commissioning any serious new research into the health impacts of cannabis,” he said.

In its final report, the federal Task Force on Cannabis Legalization and Regulation, cochaired by Ware, called for more federal leadership on supporting cannabis research. The task force suggested that a portion of government revenue from taxes on cannabis be used to fund the research. Tax revenue from medical marijuana has been growing for more than a decade, and the recreational market is projected to produce even greater revenues.

Historically, legal prohibitions on cannabis have inhibited research on its health impacts. But that is about to change, so “the federal government now needs to engage with its scientific granting agencies,” said Ware.

Figure

Urgent need for federal investment in research on cannabis health impacts, say researchers.

Image courtesy of myshkovsky/iStock

The task force’s call for more research came after consultations with scientists, policy-makers from Health Canada, and experts from the Canadian Centre on Substance Use and Addiction (CCSA), and the Canadian Institutes of Health Research (CIHR). The CCSA released a summary report outlining a national research agenda on the health impacts of nonmedical cannabis use.

This report also recommended that the government dedicate a portion of cannabis tax revenue to health research. “While the specific percentage to be dedicated needs to be determined, a minimum figure of 10% resonated with the group as a preliminary estimate,” stated the report. “There is a pressing need for access to evidence on the health-related effects of non-medical cannabis to best inform policy decisions.”

Among the areas requiring study are the linkages between youth usage and mental health problems, the dynamics of cannabis impairment, how to communicate health risks, and the impacts on pregnancy.

CIHR spokesman David Couillard said the CIHR allocated $1.4 million last summer for short-term projects in areas including cannabis and driving, workplace usage, impact on youth, regulatory impacts, data collection, pregnancy outcomes and second-hand smoke.

Meanwhile, Health Canada has made efforts to streamline the legal process for cannabis research and gain information about “the knowledge, attitudes and behaviours of Canadians who use cannabis for non-medical and medical purposes” from a survey, according to spokesperson Tammy Jarbeau.

The CCSA has cohosted a symposium on impaired driving, conducted youth focus groups to help create a communication guide, and has been involved in a project aimed at analyzing hospital data to better understand the health impacts of cannabis.

“Funding research is not a trivial task,” said Ware. “To some extent, I’m satisfied the urgency has been heard and the responses are beginning to emerge.”

But according to Michael DeVillaer of McMaster University, an expert on the epidemiology of drug problems and drug policy, the federal government’s hesitation to devote more funding to cannabis research may stem in part from a reluctance to find evidence of harm from a product that produces so much tax revenue.

“We’d hope they would put their responsibilities to support public health research over their hunger for revenue,” he said. “But research just doesn’t ever seem to have been part of the government’s agenda.”

Footnotes

  • Posted on cmajnews.com on Jan. 17, 2018.

PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 190 (5)
CMAJ
Vol. 190, Issue 5
5 Feb 2018
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Urgent need for federal investment in research on cannabis health impacts, say researchers
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Urgent need for federal investment in research on cannabis health impacts, say researchers
Paul Webster
CMAJ Feb 2018, 190 (5) E149-E150; DOI: 10.1503/cmaj.109-5554

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Urgent need for federal investment in research on cannabis health impacts, say researchers
Paul Webster
CMAJ Feb 2018, 190 (5) E149-E150; DOI: 10.1503/cmaj.109-5554
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Footnotes
  • Figures & Tables
  • Responses
  • Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Saying goodbye to CMAJ News
  • How Canadian hospitals are decreasing carbon emissions
  • National survey highlights worsening primary care access
Show more News

Similar Articles

Collections

  • Topics
    • Cannabis
    • Drugs: adverse reactions

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • CPD credits
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: [email protected]

CMA Civility, Accessibility, Privacy

 

Powered by HighWire